Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-25
DOI
10.3389/fcvm.2021.614997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience
- (2020) Stefan A. Koerber et al. JOURNAL OF NUCLEAR MEDICINE
- FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas
- (2020) Manuel Röhrich et al. EUROPEAN JOURNAL OF RADIOLOGY
- Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease
- (2020) Markus B. Heckmann et al. Circulation-Cardiovascular Imaging
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor FAPI-04
- (2019) Zohreh Varasteh et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting cardiac fibrosis with engineered T cells
- (2019) Haig Aghajanian et al. NATURE
- Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
- (2019) Yu-Wen Zhou et al. Frontiers in Pharmacology
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- A new method for tumor imaging by targeting cancer associated fibroblasts
- (2018) Anastasia Loktev et al. JOURNAL OF NUCLEAR MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers
- (2018) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- Myocardial Fibrosis in Hypertrophic Cardiomyopathy
- (2013) Gil Moravsky et al. JACC-Cardiovascular Imaging
- Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
- (2013) Koen Jansen et al. ACS Medicinal Chemistry Letters
- 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology
- (2011) Ornella Leone et al. CARDIOVASCULAR PATHOLOGY
- Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions
- (2011) Yan Huang et al. CLINICAL & EXPERIMENTAL METASTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started